Chatham Lodging Trust (CLDT) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Successfully refinanced $280 million of maturing debt, leaving only $30 million due in the next year and no liquidity issues.
Acquired a new 148-room Home2 Suites by Hilton in downtown Phoenix for $43.3 million, marking the first acquisition since 2022.
Revenue for Q2 2024 increased 2.4% year-over-year to $86.5 million, driven by a 3.6% rise in same property RevPAR and the new hotel acquisition.
Net income for Q2 2024 was $7.0 million, down from $9.4 million in Q2 2023, primarily due to higher operating and interest expenses.
Opportunistically marketing several hotels for sale, expecting $40–$80 million in proceeds.
Financial highlights
Q2 2024 hotel EBITDA was $33.7 million, adjusted EBITDA $31.4 million, and adjusted FFO $0.39 per share.
Same property RevPAR for Q2 2024 increased 3.6% year-over-year to $150.69, with occupancy at 82.3% and ADR at $183.16.
Hotel EBITDA margin was 39%, down from 41.3% in Q2 2023, and GOP margin reached 46%.
Interest expense increased 19.9% to $7.7 million in Q2 2024, reflecting higher debt balances and rates.
Cash, cash equivalents, and restricted cash totaled $25.7 million as of June 30, 2024.
Outlook and guidance
Q3 2024 guidance: RevPAR growth of 0%–2.5%, adjusted EBITDA of $28–$31 million, adjusted FFO per share of $0.31–$0.36.
Net income guidance for Q3: $3–$5 million ($0.01–$0.06 per diluted share).
The company plans to invest approximately $18.1 million in renovations and improvements for the rest of 2024.
Short-term liquidity needs are expected to be met through cash balances and credit facility availability.
Fourth quarter RevPAR expected to be similar to third quarter.
Latest events from Chatham Lodging Trust
- Industry-leading margins and RevPAR, strong balance sheet, and upside from tech market recovery.CLDT
Investor presentation2 Mar 2026 - Industry-leading margins, reduced leverage, and a return to profitability set the stage for 2026.CLDT
Q4 202527 Feb 2026 - Q3 RevPAR growth, asset sales, and tech market strength support debt reduction and outperformance.CLDT
Q3 202416 Jan 2026 - Q4 RevPAR up 4%, margins expand, and leverage falls as tech markets drive growth.CLDT
Q4 202423 Dec 2025 - Proxy covers trustee elections, auditor ratification, executive pay, and equity plan amendment.CLDT
Proxy Filing2 Dec 2025 - Shareholders will vote on directors, auditor ratification, compensation, and plan amendment.CLDT
Proxy Filing2 Dec 2025 - Board urges approval of Equity Incentive Plan amendment to sustain aligned, cost-effective pay.CLDT
Proxy Filing2 Dec 2025 - Outperforming peers in RevPAR and margins, with strong growth potential from business travel recovery.CLDT
Investor Presentation27 Nov 2025 - Q2 2025 delivered resilient RevPAR, reduced leverage, and robust share repurchases.CLDT
Q2 202523 Nov 2025